Docusign (NASDAQ:DOCU) CFO Blake Jeffrey Grayson Sells 15,000 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 15,000 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $45.55, for a total transaction of $683,250.00. Following the sale, the chief financial officer owned 141,429 shares in the company, valued at $6,442,090.95. This represents a 9.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Trading Up 3.6%

Shares of NASDAQ:DOCU opened at $46.02 on Thursday. The company has a market cap of $8.79 billion, a price-to-earnings ratio of 29.88, a PEG ratio of 1.31 and a beta of 0.90. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $86.65. The company has a 50-day moving average price of $46.93 and a 200 day moving average price of $51.11.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, June 4th. The company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The company had revenue of $830.24 million for the quarter, compared to analysts’ expectations of $824.71 million. During the same period in the previous year, the firm posted $0.90 earnings per share. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, equities analysts forecast that Docusign Inc. will post 2.03 EPS for the current year.

Docusign declared that its Board of Directors has approved a share buyback program on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 21% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

DOCU has been the topic of several recent research reports. JPMorgan Chase & Co. decreased their price target on Docusign from $78.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, March 18th. Bank of America began coverage on shares of Docusign in a research report on Tuesday, March 31st. They set an “underperform” rating and a $52.00 price objective on the stock. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Piper Sandler lowered their target price on shares of Docusign from $75.00 to $52.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Finally, Citigroup lifted their price target on shares of Docusign from $50.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $60.27.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Institutional Trading of Docusign

Several institutional investors and hedge funds have recently modified their holdings of DOCU. Central Pacific Bank Trust Division purchased a new stake in shares of Docusign in the fourth quarter valued at approximately $25,000. Modus Advisors LLC bought a new stake in Docusign during the 4th quarter valued at $27,000. Torren Management LLC purchased a new stake in shares of Docusign in the 4th quarter worth $28,000. Aventura Private Wealth LLC purchased a new stake in shares of Docusign in the 4th quarter worth $30,000. Finally, True Wealth Design LLC increased its stake in shares of Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after buying an additional 222 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.